跳至主要内容
临床试验/ISRCTN11265821
ISRCTN11265821进行中(未招募)未知

ong-term follow-up study of patients with COVID-19 associated pneumonia who participated in a designated Genentech/Roche sponsored study or Genentech/Roche supported investigator-initiated placebo-controlled or active-controlled study

Genentech, Inc0 个研究点目标入组 300 人开始时间: 2021年1月21日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Informed consent by any patient capable of giving consent, or, when the patient is not capable of giving consent, by their legal/authorized representative
  • 2. Aged =18 years at the time of providing informed consent
  • 3. Able to comply with the study procedures, in the investigator's judgment
  • 4. Participated in any Genentech/Roche sponsored study or any supported Genentech/Roche independent investigator study for COVID-19 associated pneumonia (Note: Includes patients who completed or discontinued early from these studies)

排除标准

  • 1. Participation in an interventional study at the time of enrollment or plans to enroll in an interventional study during this study
  • 2. Any serious medical condition or abnormality of clinical laboratory tests that, in the investigator’s judgment, precludes the patient’s safe participation in and completion of the study

研究者

相似试验